Total Payments
$4,892
2024 Payments
$1,802
Companies
30
Transactions
278
Medicare Patients
5,599
Medicare Billing
$685,862
Payment Breakdown by Category
Food & Beverage$4,699 (96.1%)
Education$193.09 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,699 | 274 | 96.1% |
| Education | $193.09 | 4 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,541 | 124 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,239 | 48 | $0 (2024) |
| GENZYME CORPORATION | $346.01 | 16 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $225.25 | 12 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $150.55 | 8 | $0 (2024) |
| Philips Electronics North America Corporation | $140.53 | 8 | $0 (2023) |
| Vapotherm Inc | $131.51 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $118.33 | 8 | $0 (2024) |
| Amgen Inc. | $94.19 | 6 | $0 (2024) |
| Ceribell, Inc. | $85.13 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,802 | 82 | AstraZeneca Pharmaceuticals LP ($557.23) |
| 2023 | $1,434 | 72 | GlaxoSmithKline, LLC. ($466.73) |
| 2022 | $395.26 | 30 | GlaxoSmithKline, LLC. ($261.35) |
| 2021 | $130.91 | 8 | GlaxoSmithKline, LLC. ($68.57) |
| 2020 | $285.14 | 29 | GlaxoSmithKline, LLC. ($153.94) |
| 2019 | $314.68 | 18 | Vapotherm Inc ($104.31) |
| 2018 | $136.52 | 20 | GlaxoSmithKline, LLC. ($109.26) |
| 2017 | $393.27 | 19 | AstraZeneca Pharmaceuticals LP ($188.39) |
All Payment Transactions
278 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $101.30 | General |
| Category: Immunology | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.32 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Inflammation | ||||||
| 10/14/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: HFCWO | ||||||
| 10/08/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.72 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Immunology | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Respiratory | ||||||
| 09/06/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $78.99 | General |
| Category: Immunology | ||||||
| 08/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.95 | General |
| Category: Immunology | ||||||
| 08/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $13.98 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,360 | 1,756 | $472,320 | $163,316 |
| 2022 | 21 | 1,471 | 1,942 | $522,477 | $181,610 |
| 2021 | 17 | 1,455 | 1,932 | $514,840 | $180,025 |
| 2020 | 17 | 1,313 | 1,735 | $451,563 | $160,911 |
Total Patients
5,599
Total Services
7,365
Medicare Billing
$685,862
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 247 | 349 | $99,116 | $36,674 | 37.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 70 | 161 | $95,956 | $29,172 | 30.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 194 | 315 | $50,528 | $21,069 | 41.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 123 | 180 | $43,172 | $17,739 | 41.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 118 | 121 | $52,030 | $17,464 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 147 | $29,400 | $10,796 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $22,995 | $8,093 | 35.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $10,592 | $4,478 | 42.3% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 86 | 87 | $16,095 | $4,359 | 27.1% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 73 | 74 | $13,320 | $3,494 | 26.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $6,715 | $2,365 | 35.2% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 66 | 66 | $7,260 | $1,922 | 26.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 52 | 52 | $10,400 | $1,730 | 16.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 33 | 33 | $5,280 | $1,106 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,706 | $1,036 | 38.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 36 | 37 | $4,440 | $864.00 | 19.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 16 | 16 | $720.00 | $525.92 | 73.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 11 | 11 | $1,595 | $429.66 | 26.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 78 | 204 | $121,584 | $37,852 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 298 | $84,774 | $32,124 | 37.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 263 | 414 | $64,170 | $24,541 | 38.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 144 | 148 | $63,640 | $24,409 | 38.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 165 | 253 | $55,913 | $21,682 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 151 | 176 | $35,200 | $11,756 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 42 | 42 | $15,210 | $5,565 | 36.6% |
About Dr. Emilio Mazza, MD
Dr. Emilio Mazza, MD is a Pulmonary Disease healthcare provider based in Marlton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184663239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emilio Mazza, MD has received a total of $4,892 in payments from pharmaceutical and medical device companies, with $1,802 received in 2024. These payments were reported across 278 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($4,699).
As a Medicare-enrolled provider, Mazza has provided services to 5,599 Medicare beneficiaries, totaling 7,365 services with total Medicare billing of $685,862. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Marlton, NJ
- Active Since 06/05/2006
- Last Updated 02/10/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1184663239
Products in Payments
- TRELEGY ELLIPTA (Drug) $605.54
- DUPIXENT (Biological) $547.13
- NUCALA (Biological) $536.07
- FASENRA (Biological) $348.95
- ANDEXXA (Biological) $224.46
- AIRSUPRA (Drug) $176.71
- BREZTRI (Drug) $172.27
- (8874) inCourage (Device) $140.53
- ANORO (Drug) $131.17
- AREXVY (Drug) $125.00
- WAKIX (Drug) $113.33
- Wakix (Drug) $111.92
- TEZSPIRE (Biological) $107.98
- Precision Flow (Device) $104.31
- POCKET EEG DEVICE (Device) $85.13
- ClearSight System (Device) $82.48
- TYVASO (Drug) $76.35
- Hillrom - Life 2000 Ventilation System (Device) $72.57
- SYMBICORT (Drug) $69.54
- (AK6) Vest Therapy (Device) $68.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Marlton
Dr. Mark Weir, Mb Chb, MB CHB
Pulmonary Disease — Payments: $7,553
Pulmonary Disease $7,553
Dr. Eric Sztejman, Md, MD
Pulmonary Disease — Payments: $4,910
Pulmonary Disease $4,910
Allen Salm, Md, MD
Pulmonary Disease — Payments: $4,688
Pulmonary Disease $4,688
Abhishek Agarwal, Md, MD
Pulmonary Disease — Payments: $4,388
Pulmonary Disease $4,388
Matthew Gordon, Md, MD
Pulmonary Disease — Payments: $4,385
Pulmonary Disease $4,385
Dr. Jonathan Galli, M.d, M.D
Pulmonary Disease — Payments: $3,450
Pulmonary Disease $3,450